Omnicell, Inc. cash flow to debt ratio of 62.30% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Omnicell, Inc.'s free cash flow has decreased 42.56% from $151.26M last year to $86.89M, signaling decreasing performance

Omnicell, Inc.'s debt to equity ratio is 0.15, which means that the company's assets are healthy financed, signaling financial stability.

Omnicell, Inc.'s debt has decreased relative to shareholder equity from 0.31 last year to 0.15 today, signaling strengthened financials

Omnicell, Inc. has a net cash position, so leverage is healthy.

Omnicell, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Omnicell, Inc.'s profit margin has increased (178.25%) in the last year from 1.13% to 3.13%, signaling increasing performance

Omnicell, Inc.'s short-term assets of $680.07M exceed its short-term liabilities of $476.61M

Omnicell, Inc.'s return on assets of 1.96% is lower than the 5.00% threshold, indicating inefficient asset utilization

Omnicell, Inc.'s return on equity of 3.13%, is lower than 15.00%, indicating bad performance

Omnicell, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Omnicell, Inc. had positive net income in 4 out of 5 years, indicating stable and consistent earnings

Omnicell, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Omnicell, Inc. has a free cash flow yield of 5.12%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Omnicell, Inc.'s yearly earnings has decreased 83.62% since last year from $12.53M to $2.05M, signaling decreasing performance

Omnicell, Inc.'s yearly revenue has increased 6.53% since last year from $1.11B to $1.18B, signaling increasing performance

ROIC 2.41% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Omnicell, Inc.'s 3-year revenue CAGR of -2.94% is negative, indicating declining revenue over the past 3 years

Omnicell, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Omnicell, Inc. had positive ROE in 4 out of 5 years, indicating consistent and reliable returns on equity

Omnicell, Inc. is overvalued relative to its fair value price of 15.67 based on Discounted Cash Flow model

Omnicell, Inc. has an earnings yield of 2.30%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Omnicell, Inc. is overvalued relative to its fair value price of 14.67 based on EBITDA multiple model

Omnicell, Inc. has an EV/EBITDA ratio of 16.59x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Omnicell, Inc. is overvalued relative to its fair value price of 0.03 based on Earnings Fair Value model

Omnicell, Inc.'s earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

Omnicell, Inc. has a price-to-book ratio of 1.31x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Omnicell, Inc. has a price-to-sales ratio of 1.36x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue